CTI BioPharma (FRA:CEPS) YoY EPS Growth : 72.32% (As of Mar. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. CTI BioPharma's YoY EPS Growth for the quarter that ended in Mar. 2023 was 72.32%.

CTI BioPharma's Earnings per Share (Diluted) for the three months ended in Mar. 2023 was €-0.09.

CTI BioPharma YoY EPS Growth Historical Data

The historical data trend for CTI BioPharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma YoY EPS Growth Chart

CTI BioPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EPS Growth

Get a 7-Day Free Trial

56.39

-35.89

2.09

-58.72

20.73

CTI BioPharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
YoY EPS Growth	Get a 7-Day Free Trial															-74.09	-14.37	40.72	60.71	72.32

CTI BioPharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

CTI BioPharma's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EPS Growth (A: Dec. 2022 )
=	(Earnings per Share (Diluted) (A: Dec. 2022 )	-	Earnings per Share (Diluted) (A: Dec. 2021 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2021 ) \|
=	(-0.765	-	-0.965)	/	\| -0.965 \|
=	20.73 %

CTI BioPharma's YoY EPS Growth for the quarter that ended in Mar. 2023 is calculated as:

	YoY EPS Growth (Q: Mar. 2023 )
=	(Earnings per Share (Diluted) (Q: Mar. 2023 )	-	Earnings per Share (Diluted) (Q: Mar. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2022 )) \|
=	(-0.093	-	-0.336)	/	\| -0.336 \|
=	72.32 %

CTI BioPharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CTI BioPharma (FRA:CEPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121

Website

https://www.ctibiopharma.com

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines